The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells

Clinical and Experimental Immunology

Volumn 134, Issue 2, 2003, Pages 238-245

  Leckel, K ^a   Beecken, W D ^a   Jonas, D ^a   Oppermann, E ^a   Coman, M C ^a   Beck, K F ^b   Cinatl, J ^c   Hailer, N P ^d   Auth, M K H ^e   Bechstein, W O ^a   Shipkova, M ^f   Blaheta, R A ^a,d  

^a Zentrum der Chirurgie   (Germany)

^b Zentrum der Pharmakologie   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adhesion; Mycophenolate mofetil; Receptor expression; T cells; Tumour cells; WiDr

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NORTHERN BLOTTING; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; WESTERN BLOTTING;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL ADHESION MOLECULES; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTEGRINS; MYCOPHENOLIC ACID; TUMOR CELLS, CULTURED;

EID: 0242521307     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02290.x     Document Type: Article

References (27)

1. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000; 47:85-118.
2. Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transpl Immunol 1996; 4:64-7.
3. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999; 55:945-55.
4. Blaheta RA, Leckel K, Wittig B et al. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol 1998; 6:251-9.
5. Ventura CG, Coimbra TM, De Campos SB, De Castro IYuL, Seguro AC. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 2002; 13:2524-33.
6. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998; :147-58.
7. Garver RI Jr, Zorn GL, Wu X, McGiffin DC, Young KR Jr, Pinkard NB. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med 1999; 340:1071-4.
8. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69:1633-7.
9. Haagsma EB, Hagens VE, Schaapveld M et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34:84-91.
10. Tremblay F, Fernandes M, Habbab F, Edwardes MD, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 2002; 9:785-8.
11. Blaheta RA, Kronenberger B, Woitaschek D et al. Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity. J Immunol Meth 1998; 211:159-69.
12. Wittig BM, Thees R, Kaulen H et al. Alpha (1,3) fucosyltransferase expression in E-selectin-mediated binding of gastrointestinal tumor cells. Int J Cancer 1996; 67:80-5.
13. Franchetti P, Grifantini M. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Curr Med Chem 1999; 6:599-614.
14. Hauser IA, Johnson DR, Thevenod F, Goppelt-Strube M. Effect of mycophenolic acid on TNF alpha-induced expression of cell adhesion molecules in human venous endothelial cells in vitro. Br J Pharmacol 1997; 122:1315-22.
15. OI Otvos L Kieber-Emmons T Blaszczyk-Thurin M. Role of SA-Le (a) and E-selectin in metastasis assessed with peptide antagonist. Peptides 2002; 23:999-1010.
16. Tomlinson J Wang JL Barsky SH Lee MC Bischoff J Nguyen M. Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol 2000; 16:347-53.
17. Fukuda MN Ohyama C Lowitz K et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res 2000; 60:450-6.
18. Weston BW, Hiller KM, Mayben JP et al. Expression of human alpha (1,3) fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res 1999; 59:2127-35.
19. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 2002; 86:161-7.
20. Flugy AM, D'Amato M, Russo D et al. E-selectin modulates the malignant properties of T84 colon carcinoma cells. Biochem Biophys Res Commun 2002; 293:1099-106.
21. Kumamoto K, Goto Y, Sekikawa K et al. Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants. Cancer Res 2001; 61:4620-7.
22. Nakamori S, Nishihara S, Ikehara Y et al. Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. J Exp Clin Cancer Res 1999; 18:425-32.
23. Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB. Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 1994; 269:16789-94.
24. Blander JM, Visintin I, Janeway CA Jr, Medzhitov R. Alpha (1,3)-fucosyltransferase VII and alpha (2,3)-sialyltransferase IV are upregulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites. J Immunol 1999; 163:3746-52.
25. Kudo T, Ikehara Y, Togayachi A et al. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 1998; 78:797-811.
26. Matsuura N, Narita T, Hiraiwa N et al. Gene expression of fucosyl-and sialyl-transferases which synthesize sialyl Lewis x, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol 1998; 12:1157-64.
27. Madhavan M, Srinivas P, Abraham E, Ahmed I, Vijayalekshmi NR, Balaram P. Down-regulation of endothelial adhesion molecules in node positive breast cancer: possible failure of host defence mechanism. Pathol Oncol Res 2002; 8:125-8.